Haemophilia drug raises CSL outlook for 2022-2023

MELBOURNE: Broker Wilsons values CSL’s drug development pipeline at $62 per share and ... read more

Some Medibank customers are switching claims NIB CEO

NEWCASTLE: NIB Holdings chief executive Mark Fitzgibbon says the health insurer is starting ... read more

IFM and UniSuper set to lock in PRP cash

SYDNEY: Three banks have underwritten a $300 million-plus debt package for IFM Investors’ ... read more

Medibank files on hepatitis and HIV reportedly released

SYDNEY: The criminals who stole data from Australia’s biggest health insurer, Medibank, have ... read more